Genetic association of APOA5 and APOE with metabolic syndrome and their interaction with health-related behavior in Korean men

Lipids in Health and Disease

Volumn 14, Issue 1, 2015, Pages

  Son, Ki Young ^a,c   Son, Ho Young ^a   Chae, Jeesoo ^b   Hwang, Jinha ^b   Jang, SeSong ^b   Yun, Jae Moon ^a,c   Cho, BeLong ^a,c   Park, Jin Ho ^a,c   Kim, Jong Il ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

APOA5; APOE; Health behavior; Metabolic syndrome; Triglyceride

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN A5; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; HYPOCHOLESTEROLEMIC AGENT; TRIACYLGLYCEROL; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; APOA5 GENE; APOE GENE; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRINKING BEHAVIOR; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HEALTH BEHAVIOR; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; POPULATION GENETICS; RISK ASSESSMENT; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREAN; UNIVERSITY HOSPITAL; BLOOD; DIET RESTRICTION; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; PATHOLOGY; PATHOPHYSIOLOGY; RISK; SMOKING; SOUTH KOREA;

ADULT; ALCOHOL DRINKING; APOLIPOPROTEIN A-V; APOLIPOPROTEINS A; APOLIPOPROTEINS E; BLOOD GLUCOSE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FASTING; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEALTH BEHAVIOR; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOTOR ACTIVITY; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; RISK; SMOKING; TRIGLYCERIDES;

EID: 84941559031     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-015-0111-5     Document Type: Article

References (41)

1. Alwan A. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011.
2. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation. 2004;109(3):433-8.
3. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683-9.
4. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004;164(10):1066-76.
5. Lim S, Shin H, Song JH, Kwak SH, Kang SM, Yoon JW, et al. Increasing prevalence of metabolic syndrome in Korea The Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care. 2011;34(6):1323-8.
6. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome a summary of the evidence. Diabetes Care. 2005;28(7):1769-78.
7. Wijndaele K, Duvigneaud N, Matton L, Duquet W, Delecluse C, Thomis M, et al. Sedentary behaviour, physical activity and a continuous metabolic syndrome risk score in adults. Eur J Clin Nutr. 2007;63(3):421-9.
8. Vattikuti S, Guo J, Chow C. Heritability and genetic correlations explained by common SNPs for metabolic syndrome traits. PLoS Genet. 2012;8(3), e1002637.
9. Povel C, Boer J, Reiling E, Feskens E. Genetic variants and the metabolic syndrome: a systematic review. Obes Rev. 2011;12(11):952-67.
10. Fall T, Ingelsson E. Genome-wide association studies of obesity and metabolic syndrome. Mol Cell Endocrinol. 2014;382(1):740-57.
11. Maasz A, Kisfali P, Horvatovich K, Mohas M, Marko L, Csongei V, et al. Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome. Pathol Oncol Res. 2007;13(3):243-7.
12. Melegh BI, Duga B, Sumegi K, Kisfali P, Maasz A, Komlosi K, et al. Mutations of the apolipoprotein A5 gene with inherited hypertriglyceridaemia: review of the current literature. Curr Med Chem. 2012;19(36):6163-70.
13. Havasi V, Szolnoki Z, Talian G, Bene J, Komlosi K, Maasz A, et al. Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke. J Mol Neurosci. 2006;29(2):177-83.
14. Kisfali P, Mohas M, Maasz A, Polgar N, Hadarits F, Marko L, et al. Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome. Nutr Metab Cardiovasc Dis. 2010;20(7):505-11.
15. Song KH, Cha S, Yu SG, Yu H, Oh SA, Kang NS. Association of apolipoprotein A5 gene -1131 T∈>∈C polymorphism with the risk of metabolic syndrome in Korean subjects. BioMed Res Int. 2013;2013:585134.
16. Lee KH, Kim OY, Lim HH, Lee YJ, Jang Y, Lee JH. Contribution of APOA5-1131C allele to the increased susceptibility of diabetes mellitus in association with higher triglyceride in Korean women. Metab Clin Exp. 2010;59(11):1583-90.
17. Li YY, Yin RX, Lai CQ, Li M, Long XJ, Li KL, et al. Association of apolipoprotein A5 gene polymorphisms and serum lipid levels. Nutr Metab Cardiovasc Dis. 2011;21(12):947-56.
18. Martinelli N, Trabetti E, Bassi A, Girelli D, Friso S, Pizzolo F, et al. The -1131 T∈>∈C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study. Atherosclerosis. 2007;191(2):409-17.
19. Caussy C, Charriere S, Marcais C, Di Filippo M, Sassolas A, Delay M, et al. An APOA5 3′ UTR variant associated with plasma triglycerides triggers APOA5 downregulation by creating a functional miR-485-5p binding site. Am J Hum Genet. 2014;94(1):129-34.
20. Dallongeville J, Lussier-Cacan S, Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res. 1992;33(4):447-54.
21. Heller DA, de Faire U, Pedersen NL, Dahlen G, McClearn GE. Genetic and environmental influences on serum lipid levels in twins. N Engl J Med. 1993;328(16):1150-6.
22. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002;155(6):487-95.
23. McCarron MO, Delong D, Alberts MJ. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology. 1999;53(6):1308-11.
24. Sima A, Iordan A, Stancu C. Apolipoprotein E polymorphism - a risk factor for metabolic syndrome. Clin Chem Lab Med. 2007;45(9):1149-53.
25. Musunuru K, Romaine SP, Lettre G, Wilson JG, Volcik KA, Tsai MY, et al. Multi-ethnic analysis of lipid-associated loci: the NHLBI CARe project. PLoS One. 2012;7(5):e36473.
26. He LN, Recker RR, Deng HW, Dvornyk V. A polymorphism of apolipoprotein E (APOE) gene is associated with age at natural menopause in Caucasian females. Maturitas. 2009;62(1):37-41.
27. Yamada Y, Kato K, Hibino T, Yokoi K, Matsuo H, Segawa T, et al. Prediction of genetic risk for metabolic syndrome. Atherosclerosis. 2007;191(2):298-304.
28. Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5.
29. Lee S, Park H, Kim S, Kwon H, Kim D, Kim D, et al. Cut-off points of waist circumference for defining abdominal obesity in the Korean population. Korean J Obes. 2006;15(1):1-9.
30. NHIS - Adult Tobacco Use Information: Center for Disease Control and Prevention. http://www.cdc.gov/nchs/nhis/tobacco/tobacco-glossary.htm. Accessed 10 Aug 2015.
31. Drinking Levels Defined: National Institute on Alcohol Abuse and Alcoholism http://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/moderate-binge-drinking. Accessed 10 Aug 2015.
32. Oh JY, Yang YJ, Kim BS, Kang JH. Validity and reliability of Korean version of International Physical Activity Questionnaire (IPAQ) short form. J Korean Acad Fam Med. 2007;28(7):532-41.
33. IPAQ Research Committee. Guidelines for data processing and analysis of the international physical activity questionnaire (IPAQ) - Short and long forms. 2005. http://www.ipaq.ki.se.
34. Liu Y, Wu G, Han L, Zhao K, Qu Y, Xu A, et al. Association of the FABP2 Ala54Thr polymorphism with type 2 diabetes, obesity, and metabolic syndrome: a population-based case-control study and a systematic meta-analysis. Genet Mol Res. 2014;14(1):1155-68.
35. Tanyolaç S, Bremer AA, Hodoglugil U, Movsesyan I, Pullinger CR, Heiner SW, et al. Genetic variants of the ENPP1/PC-1 gene are associated with hypertriglyceridemia in male subjects. Metab Syndr Relat Disord. 2009;7(6):543-8.
36. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008;40(2):189-97. doi: 10.1038/ng.75.
37. Owen KR, Groves CJ, Hanson RL, Knowler WC, Shuldiner AR, Elbein SC, et al. Common variation in the LMNA Gene (Encoding Lamin A/C) and type 2 diabetes association analyses in 9,518 subjects. Diabetes. 2007;56(3):879-83.
38. Enns JE, Taylor CG, Zahradka P. Variations in adipokine genes AdipoQ, Lep, and LepR are associated with risk for obesity-related metabolic disease: the modulatory role of gene-nutrient interactions. J Obes.2011;2011:168659. doi: 10.1155/2011/168659. Epub 2011 Apr 19.
39. Fava C, Montagnana M, Guerriero M, Almgren P, von Wowern F, Minuz P, et al. Chromosome 2q12, the ADRA2B I/D polymorphism and metabolic syndrome. J Hypertens. 2009;27(9):1794-803.
40. Mirrakhimov AE, Kerimkulova AS, Lunegova OS, Moldokeeva CB, Zalesskaya YV, Abilova SS, et al. An association between TRP64ARG polymorphism of the B3 adrenoreceptor gene and some metabolic disturbances. Cardiovasc Diabetol. 2011;10:89.
41. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-75.